Incannex Healthcare Inc. (IXHL)
Develops psychedelic and cannabis-based medicines for sleep, anxiety, and inflammatory diseases.
$2.97-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-74.4%
The outlook
IXHL is trading near its 52-week low with minimal analyst coverage showing a significant gap between the current price and average price targets. The stock sits below both its 50- and 200-day moving averages, reflecting a weak near-term trend despite bullish longer-term analyst expectations.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +499% vs current price
Market cap
$35.5M
52-wk high
$39.60
52-wk low
$2.49
50-day avg
$3.45
200-day avg
$7.01
Trailing P/E
—